Currently, the share price for Mankind Pharma Ltd. is delayed. Login to view live prices.
Mankind Pharma Ltd.
-- ( -- %) 1D
- Prev. Close1,952.85
- Upper Circuit2,148.10
- Lower Circuit1,757.60
Analyst Recommendations For Mankind Pharma Ltd.
As recommended by 13 analysts
Mankind Pharma Ltd.'s Info & Management
Mankind Pharma engaged in the manufacturing and trading of pharmaceuticals and health care products.
- Executive Director,Whole Time Director,Chief Executive OfficerMr. Sheetal Arora
- Chief Operating OfficerMr. Arjun Juneja
- DirectorMr. Prem Kumar Arora
- Chief Scientific OfficerDr. Anil Kumar
- Chief Marketing OfficerDr. Sanjay Koul
- President(Global Quality)Dr. Birendra Singh
FAQs on Mankind Pharma Ltd.
What is the share price of Mankind Pharma Ltd.?
Mankind Pharma Ltd. share price is ₹1,920.05 as of December 11, 2023, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).
What is the 52-week high and low of Mankind Pharma Ltd.?
The 52-week high and low of Mankind Pharma Ltd. is ₹2,040.70 and ₹1,244.95 respectively as of December 11, 2023, 03:29 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).
What is the PE ratio of Mankind Pharma Ltd.?
The PE ratio of Mankind Pharma Ltd. is 50.00 as of December 12, 2023.The PE ratio measures the current share price relative to the earnings of the company for past 12 months (as of last reported period).
What is the PB ratio of Mankind Pharma Ltd.?
The trailing twelve month (TTM) PB ratio of Mankind Pharma Ltd. is 10.30 as of December 12, 2023. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.
What are the Upper Circuit and Lower Circuit of Mankind Pharma Ltd.?
The Upper Circuit of Mankind Pharma Ltd. is ₹2,148.1. The Lower Circuit of Mankind Pharma Ltd. is ₹1,757.6.
What is the ROE of Mankind Pharma Ltd.?
Mankind Pharma Ltd. reported an ROE of 17.24% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.
What is the shareholding pattern of Mankind Pharma Ltd.?
Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Mankind Pharma Ltd., Promoter held 76.5%, the FII held 4.2%, DII held 4.6% and the public held 14.8% of the total shares.
How to buy Mankind Pharma Ltd. Share?
What is the fair value of Mankind Pharma Ltd.?
The fair value of Mankind Pharma Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.